Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1

A new and rapid colorimetric determination of acetylcholinesterase activity

Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,221 · see citing works

A synaptic model of memory: long-term potentiation in the hippocampus

Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · see citing works

The cholinergic hypothesis of geriatric memory dysfunction

Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · see citing works

Pathobiology of ischaemic stroke: an integrated view

Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943 · see citing works

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,050 · see citing works

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991) · Science · doi:10.1126/science.1678899 · Cited by 2,711 · see citing works

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders

Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,644 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,338 · see citing works

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043 · see citing works

Apoptosis in the nervous system

Yuan, J., & Yankner, B. A. (2000) · Nature · doi:10.1038/35037739 · Cited by 1,862 · see citing works

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

Choi, D. W. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90200-7 · Cited by 1,726 · see citing works

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682 · see citing works

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618 · see citing works

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403 · see citing works

Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD‐specific caspase activation and independently of mitochondrial transmembrane depolarization

Bossy‐Wetzel, E., Newmeyer, D. D., & Green, D. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.37 · Cited by 1,225 · see citing works

The changing landscape of ischaemic brain injury mechanisms

Lee, J.-M., Zipfel, G. J., & Choi, D. W. (1999) · Nature · doi:10.1038/399a007 · Cited by 1,102 · see citing works

The mitochondrion in apoptosis: how Pandora's box opens

Zamzami, N., & Kroemer, G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048073 · Cited by 1,029 · see citing works

A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

Knapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 997 · see citing works

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease

HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938 · see citing works

Calcium: still center-stage in hypoxic-ischemic neuronal death

Choi, D. W. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80018-w · Cited by 908 · see citing works

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

Harel, M., Schalk, I. J., Ehret‐Sabatier, L., Bouet, F., Goeldner, M. P., HIRTH, C. G., Axelsen, P. H., Silman, I., & Sussman, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9031 · Cited by 902 · see citing works

Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine Receptors

Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898 · see citing works

Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 833 · see citing works

The Molecular Forms of Cholinesterase and Acetylcholinesterase in Vertebrates

Massoulié, J., & Bon, S. (1982) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.05.030182.000421 · Cited by 818 · see citing works

Mitochondrial permeability transition: a common pathway to necrosis and apoptosis

Js, K., He, L., & Lemasters, J. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00618-1 · Cited by 756 · see citing works

The permeability transition pore complex: another view

Halestrap, A. P., McStay, G. P., & Clarke, S. J. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01375-5 · Cited by 709 · see citing works

A Controlled Trial of Tacrine in Alzheimer's Disease

Farlow, M. R. (1992) · JAMA · doi:10.1001/jama.268.18.2523 · Cited by 632 · see citing works

Mediation of Neuronal Apoptosis by Enhancement of Outward Potassium Current

Yu, S. P., Yeh, C.-H., Sensi, S. L., Gwag, B. J., Canzoniero, L. M. T., Farhangrazi, Z. S., Ying, H. S.-C., Tian, M., Dugan, L. L., & Choi, D. W. (1997) · Science · doi:10.1126/science.278.5335.114 · Cited by 579 · see citing works

Excitotoxic injury of the neostriatum: a model for Huntington's disease

DiFiglia, M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90111-m · Cited by 474 · see citing works

Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases

Hefti, F., Hartikka, J., & Knusel, B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90118-8 · Cited by 466 · see citing works

Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease

Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08501.x · Cited by 450 · see citing works

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

Bowen, D. M., Allen, S. J., Benton, J. S., Goodhardt, M., Haan, E., Palmer, A. M., Sims, N. R., Smith, C., Spillane, J. A., Esiri, M. M., et al. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11838.x · Cited by 443 · see citing works

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A

Raves, M. L., Harel, M., Pang, Y., Silman, I., Kozikowski, A. P., & Sussman, J. L. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0197-57 · Cited by 373 · see citing works

Calcium and Excitotoxic Neuronal Injury

Choi, D. W. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44407.x · Cited by 344 · see citing works

Calcium: still center-stage in hypoxic-ischemic neuronal death

Choi, D. W. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93870-4 · Cited by 280 · see citing works

Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain

Mufson, E. J., Bothwell, M. A., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279 · see citing works

Age-related changes in multiple neurotransmitter systems in the monkey brain

Wenk, G. L., Pierce, D. J., Struble, R. G., Price, D. L., & Cork, L. C. (1989) · Neurobiology of Aging · doi:10.1016/s0197-4580(89)80005-3 · Cited by 222 · see citing works

Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications

Giacobini, E. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00124-1 · Cited by 211 · see citing works

Glutamate‐Mediated Injury in Focal Cerebral Ischemia: The Excitotoxin Hypothesis Revised

Hossmann, K. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00808.x · Cited by 199 · see citing works

Molecular forms of acetylcholinesterase in brain, nerve and muscle: Nature, localization and dynamics

Brimijoin, S. (1983) · Progress in Neurobiology · doi:10.1016/0301-0082(83)90015-1 · Cited by 196 · see citing works

Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death

Yu, S. P., Farhangrazi, Z. S., Ying, H. S.-C., Yeh, C.-H., & Choi, D. W. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0186 · Cited by 189 · see citing works

Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease

Gasparini, L., Racchi, M., Binetti, G. G., Trabucchi, M., Solerte, S. B., Alkon, D. L., Etcheberrigaray, R., Gibson, G. E., Blass, J. P., Paoletti, R., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.17 · Cited by 175 · see citing works

Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butylcholinesterase in vitro

OGURA, H., Kosasa, T., Kuriya, Y., & Yamanishi, Y. (2000) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2000.22.8.701373 · Cited by 162 · see citing works

ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

Turski, L., Huth, A., Sheardown, M. J., McDonald, F., Neuhaus, R., Schneider, H. H., Dirnagl, U., Wiegand, F., Jacobsen, P., & Ottow, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10960 · Cited by 162 · see citing works

Cholinesterase inhibitors in the treatment of dementia.

Ellis, J. M. (2005) · PubMed · Cited by 159 · see citing works

Cholinesterase inhibitors increase secretion of APPs in rat brain cortex

Mori, F., Lai, C.-C., Fusi, F., & Giacobini, E. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00012 · Cited by 157 · see citing works

Huperzine A attenuates amyloid β‐peptide fragment 25‐35‐induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase‐3 activation

Xiao, X., Zhang, H., & Tang, X. C. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10075 · Cited by 153 · see citing works

Elevated oxidative stress in models of normal brain aging and Alzheimer's disease

Butterfield, D. A., Howard, B. J., Yatin, S. M., Koppal, T., Drake, J., Hensley, K., Aksenov, M. Y., Aksenova, M. V., Subramaniam, R., Varadarajan, S., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00442-7 · Cited by 148 · see citing works

Current Research in Alzheimer Therapy

Frost, F. S. (1989) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-198910000-00019 · Cited by 145 · see citing works

Mechanism of inhibition of cholinesterases by huperzine A

Ashani, Y., Peggins, J. O., & Doctor, B. P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90649-6 · Cited by 144 · see citing works

Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat

Tang, X. C., Sarno, P. D., Sugaya, K., et al. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240220 · Cited by 142 · see citing works

A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?

Francis, P. T., Nordberg, A. K., & Arnold, S. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.010 · Cited by 140 · see citing works

Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.

Xu, S., Gao, Z., Weng, Z., Du, Z., Xu, W. A., Yang, J., Zhang, M. L., Tong, Z. H., Fang, Y., & Chai, X. S. (1995) · PubMed · Cited by 137 · see citing works

Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1–40) in rat

Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 131 · see citing works

Huperzine A, a novel promising acetylcholinesterase inhibitor

Cheng, D. H., Ren, H., & Tang, X. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00020 · Cited by 130 · see citing works

Antioxidant Treatment in Alzheimer's Disease: Current State

Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:1:1 · Cited by 126 · see citing works

Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities

Cheng, D. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00601-1 · Cited by 120 · see citing works

Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate

Ved, H. S., Koenig, M. L., Dave, J. R., & Doctor, B. P. (1997) · Neuroreport · doi:10.1097/00001756-199703030-00029 · Cited by 116 · see citing works

[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].

Zhang, Z., Wang, X., Chen, Q., et al. (2002) · PubMed · Cited by 114 · see citing works

Molecular Forms of Acetylcholinesterase in Bovine Caudate Nucleus and Superior Cervical Ganglion: Solubility Properties and Hydrophobic Character

Grassi, J., Vigny, M., & Massoulié, J. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb08651.x · Cited by 107 · see citing works

X-ray Structures of Torpedo californica Acetylcholinesterase Complexed with (+)-Huperzine A and (−)-Huperzine B: Structural Evidence for an Active Site Rearrangement,

Dvir, H., Jiang, H., Wong, D. M., Harel, M., Chetrit, M., He, X., Jin, G., Yu, G. L., Tang, X. C., Silman, I., et al. (2002) · Biochemistry · doi:10.1021/bi020151+ · Cited by 105 · see citing works

Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine

Zhao, Q., & Tang, X. C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02589-x · Cited by 104 · see citing works

Physostigmine, tacrine and metrifonate: The effect of multiple doses on acetylcholine metabolism in rat brain

Hallak, M. E., & Giacobini, E. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90093-2 · Cited by 103 · see citing works

Huperzine A and tacrine attenuate ?-amyloid peptide-induced oxidative injury

Xiao, X., Wang, R., & Tang, X. C. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000901)61:5 · Cited by 101 · see citing works

Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies

Pang, Y., & Kozikowski, A. P. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124014 · Cited by 100 · see citing works

The NMDA receptor ion channel: a site for binding of huperzine A

Gordon, R. K., Nigam, S. V., Weitz, J. A., Dave, J. R., Doctor, B. P., & Ved, H. S. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.805 · Cited by 100 · see citing works

Cholinesterases in neural development: new findings and toxicologic implications.

Brimijoin, S., & Koenigsberger, C. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s159 · Cited by 99 · see citing works

Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats

Liang, Y. Q., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.071 · Cited by 96 · see citing works

Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury

Xiao, X., Yang, J., & Tang, X. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00695-3 · Cited by 90 · see citing works

Review of the Value of Huperzine as Pretreatment of Organophosphate Poisoning

Lallement, G., Baille, V., Baubichon, D., et al. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00015-3 · Cited by 89 · see citing works

The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat

Sarno, P. D., Pomponi, M., Giacobini, E., et al. (1989) · Neurochemical Research · doi:10.1007/bf00965931 · Cited by 85 · see citing works

Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells

Xiao, X., Wang, R., Han, Y., & Tang, X. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01088-0 · Cited by 85 · see citing works

Old Chinese Herbal Medicine Used for Fever Yields Possible New Alzheimer Disease Therapy

Skolnick, A. A. (1997) · JAMA · doi:10.1001/jama.1997.03540340010004 · Cited by 84 · see citing works

Reversal of scopolamine-induced deficits in radial maze performance by (−)-huperzine A: comparison with E2020 and tacrine

Wang, T., & Tang, X. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00199-x · Cited by 82 · see citing works

Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats

Wang, L., Han, Y., & Tang, X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00291-0 · Cited by 81 · see citing works

Huperzine-A in capsules and tablets for treating patients with Alzheimer disease.

Xu, S.-S., Cai, Z., Qu, Z., Yang, R., Cai, Y.-L., Wang, G.-Q., Xue-qian, S., Zhong, X.-S., Cheng, R.-Y., Xu, W.-A., et al. (1999) · PubMed · Cited by 81 · see citing works

Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production

Tang, L., Wang, R. T., & Tang, X.-C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.026 · Cited by 79 · see citing works

[Anti-cholinesterase activity of huperzine A].

Wang, Y. E., Yue, D.-X., & Tang, X.-L. (1986) · PubMed · Cited by 77 · see citing works

Huperzine A as a pretreatment candidate drug against nerve agent toxicity

Grunwald, J., Raveh, L., Doctor, B. P., et al. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00501-x · Cited by 74 · see citing works

Regulation of Nicotinic Acetylcholine Receptor Channel Function by Acetylcholinesterase Inhibitors in Rat Hippocampal CA1 Interneurons

Fayuk, D. A., & Yakel, J. L. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000042 · Cited by 72 · see citing works

Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-α in intracerebroventricular β-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cells

Zhang, H., Yan, H., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.055 · Cited by 70 · see citing works

Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen–glucose deprivation

Zhou, J., Fu, Y., & Tang, X. C. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01855-9 · Cited by 70 · see citing works

[Drug evaluation of huperzine A in the treatment of senile memory disorders].

ZHANG, R.-Q., Tang, X. C., Han, Y. Y., Sang, G.-W., Zhang, Y. D., X, Y., ZHANG, C.-W., & Yang, R. M. (1991) · PubMed · Cited by 69 · see citing works

Huperzine A attenuates cognitive deficits and hippocampal neuronal damage after transient global ischemia in gerbils.

Zhou, J., Zhang, H.-Y., & Tang, X.-C. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02265-0 · Cited by 66 · see citing works

Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia ischemia

Wang, L. S., Zhou, J., Shao, X. M., & Tang, X. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02977-3 · Cited by 65 · see citing works

Huperzine A attenuates apoptosis and mitochondria‐dependent caspase‐3 in rat cortical neurons

Zhou, J., & Tang, X. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03107-1 · Cited by 61 · see citing works

NMDA receptors: from genes to channels

Sucher, N. J. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)10046-8 · Cited by 61 · see citing works

Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells

Tang, L., Rui, W. A. N. G., & Tang, X.-C. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00130.x · Cited by 60 · see citing works

Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in vitro and in vivo

Tang, X.-C., Kindel, G. H., Kozikowski, A. P., & Hanin, I. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)01182-6 · Cited by 60 · see citing works

Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.

Wang, H., & Tang, X. C. (1998) · PubMed · Cited by 59 · see citing works

Improving Effects of Huperzine A on Spatial Working Memory in Aged Monkeys and Young Adult Monkeys with Experimental Cognitive Impairment

Ye, J. W., Cai, J. X., Wang, L. M., & Tang, X. C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38024-3 · Cited by 59 · see citing works

Huperzine A attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells

Wang, R. C., Xiao, X., & Tang, X. C. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00009 · Cited by 58 · see citing works

Stereoselectivities of enantiomers of huperzine A in protection against β-amyloid25–35-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice

Zhang, H., Liang, Y. Q., Tang, X. C., He, X., & Bai, D. L. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02437-5 · Cited by 56 · see citing works

Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism

Racchi, M., & Govoni, S. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01380-2 · Cited by 52 · see citing works

Pharmacokinetics of tablet huperzine A in six volunteers.

Qian, B., Wang, M., Zhou, Z., et al. (1995) · PubMed · Cited by 52 · see citing works

Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases

Saxena, A., Doctor, B. P., Qian, N., et al. (1994) · Protein Science · doi:10.1002/pro.5560031017 · Cited by 51 · see citing works

Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by a Coptidis Rhizoma Extract and Protoberberine Alkaloids

Shigeta, K., Ootaki, K., Tatemoto, H., Nakanishi, T., Inada, A., & Muto, N. (2002) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.66.2491 · Cited by 51 · see citing works

Efficacy of huperzine in preventing soman‐induced seizures, neuropathological changes and lethality

Lallement, G., Veyret, J., Masqueliez, C., et al. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00200.x · Cited by 49 · see citing works

Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students.

Sun, Q. Q., Xu, S., Pan, J. L., Guo, H. M., & Cao, W. Q. (1999) · PubMed · Cited by 47 · see citing works

Acute and chronic studies with the anticholinesterase huperzine a: Effect on central nervous system cholinergic parameters

Laganiere, S., Corey, J., Tang, X. C., Wülfert, E., & Hanin, I. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90184-d · Cited by 47 · see citing works

[Effects of huperzine A on learning and the retrieval process of discrimination performance in rats].

Tang, X.-C., Han, Y., Chen, X., et al. (1986) · PubMed · Cited by 47 · see citing works

Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons

Zhang, J.-M., & Hu, G. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00206-8 · Cited by 45 · see citing works

Suppressive action produced by β-amyloid peptide fragment 31–35 on long-term potentiation in rat hippocampus is N-methyl-d-aspartate receptor-independent: it's offset by (−)huperzine A

Ye, L., & Qiao, J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00795-8 · Cited by 45 · see citing works

The Effect of Cholinesterase Inhibitors on the Secretion of APPS from Rat Brain Cortexa

GIACOBINI, E., MORI, F., & Lai, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34451.x · Cited by 42 · see citing works

Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines

Zhu, X. ‐., & Giacobini, E. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410613 · Cited by 39 · see citing works

Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys

Ou, L. Y., Tang, X. C., & Cai, J. X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01500-x · Cited by 38 · see citing works

Protective effect of tetramethylpyrazine on learning and memory function in D-galactose-lesioned mice.

Zhang, C., Wang, S., Zuo, P., Cui, X., & Cai, J. (2004) · PubMed · Cited by 37 · see citing works

Improving effects of huperzine A on abnormal lipid peroxidation and superoxide dismutase in aged rats.

Shang, Y., Ye, J. W., & Tang, X. C. (1999) · PubMed · Cited by 36 · see citing works

Modulation of NMDA receptor by huperzine A in rat cerebral cortex.

Wang, X. D., Zhang, J., Yang, H., et al. (1999) · PubMed · Cited by 35 · see citing works

Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression

Ahlemeyer, B., H�hne, R., & Krieglstein, J. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6 · Cited by 34 · see citing works

Effect of Huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats

Xiong, Z. Q., & Tang, X. C. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00416-g · Cited by 30 · see citing works

SUBCHRONIC ADMINISTRATION OF PYRIDOSTIGMINE OR HUPERZINE TO PRIMATES: COMPARED EFFICACY AGAINST SOMAN TOXICITY

Lallement, G., Demoncheaux, J., Foquin, A., et al. (2002) · Drug and Chemical Toxicology · doi:10.1081/dct-120005893 · Cited by 29 · see citing works

Liquid chromatographic–tandem mass spectrometric method for the quantitation of huperzine A in dog plasma

Wang, Y., Chu, D., Gu, J., et al. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.01.013 · Cited by 28 · see citing works

Presenilins Upregulate Functional K+Channel Currents in Mammalian Cells

Malin, S. A., Guo, W., Jafari, G., Goate, A., & Nerbonne, J. M. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0167 · Cited by 28 · see citing works

[Effects of huperzine A and B on skeletal muscle and the electroencephalogram].

Yan, X., Lu, W.-H., Lou, W.-J., & Tang, X. C. (1987) · PubMed · Cited by 28 · see citing works

[Improving effect of huperzine A on discrimination performance in aged rats and adult rats with experimental cognitive impairment].

Lu, W.-H., Shou, J., & Tang, X.-C. (1988) · PubMed · Cited by 28 · see citing works

Huperzine A protects rat pheochromocytoma cells against oxygen–glucose deprivation

Zhou, J., Fu, Y., & Tang, X. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00007 · Cited by 27 · see citing works

Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy

Skolnick, A. A. (1997) · JAMA · doi:10.1001/jama.277.10.776 · Cited by 24 · see citing works

Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase

Boudinot, É., Taysse, L., Daulon, S., et al. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.014 · Cited by 23 · see citing works

Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex

Zhang, Y., Zhao, X., Chen, X.-Q., Wang, Y., Yang, H., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02565-4 · Cited by 22 · see citing works

Huperzine A, a nootropic agent, inhibits fast transient potassium current in rat dissociated hippocampal neurons

Li, Y., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00167-2 · Cited by 22 · see citing works

Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance.

Ye, J. W., Shang, Y., Wang, Z. M., et al. (2000) · PubMed · Cited by 22 · see citing works

[Improvement of impaired memory in mice by huperzine A and huperzine B].

Zhu, X., & Tang, X.-C. (1988) · PubMed · Cited by 22 · see citing works

Huperzine A attenuates the neurotoxic effect of staurosporine in primary rat cortical neurons

Zhang, H., & Tang, X. C. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00023-5 · Cited by 21 · see citing works

Huperzine A ameliorates the spatial working memory impairments induced by AF64A

Xiong, Z. Q., Han, Y., & Tang, X. (1995) · Neuroreport · doi:10.1097/00001756-199511000-00029 · Cited by 21 · see citing works

Acute effects of huperzine A and tacrine on rat liver.

Ma, X., Xin, J., Wang, H.-X., Zhang, T., & Tu, Z.-H. (2003) · PubMed · Cited by 19 · see citing works

Effects of synthetic (-)-huperzine A on cholinesterase activities and mouse water maze performance.

Liu, J., Zhang, H. Y., Tang, X., et al. (1998) · PubMed · Cited by 19 · see citing works

Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons

Darvesh, S., Arora, R. C., Martin, E. V., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.002 · Cited by 19 · see citing works

Therapeutic effects of huperzine A on the aged with memory impairment

Zhang, S. (1986) · Cited by 18 · see citing works

Effects of huperzine A on nucleus basalis magnocellularis lesion-induced spatial working memory deficit.

Xiong, Z. Q., Cheng, D. H., & Tang, X. (1998) · PubMed · Cited by 17 · see citing works

[Pharmacokinetics of huperzine A in rats and mice].

Wang, Y. E., Feng, J., Lu, W.-H., et al. (1988) · PubMed · Cited by 17 · see citing works

Huperzine A reverses scopolamine- and muscimol-induced memory deficits in chick.

Gao, Y., Tang, X. C., Guan, L. C., et al. (2000) · PubMed · Cited by 16 · see citing works

Modulation of Memory by Benzodiazepine-Acetylcholine Interactions

Walsh, T. J., & Stackman, R. W. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9843-5_20 · Cited by 16 · see citing works

Similar potency of the enantiomers of huperzine A in inhibition of [3H]dizocilpine (MK-801) binding in rat cerebral cortex

Zhang, Y., Chen, X.-Q., Yang, H., Jin, G., Bai, D., & Hu, G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01615-3 · Cited by 16 · see citing works

Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A

Ma, X., Wang, H., Xin, J., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01290-1 · Cited by 15 · see citing works

Huperzine A inhibits the sustained potassium current in rat dissociated hippocampal neurons

Li, Y., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00620-1 · Cited by 15 · see citing works

Ion-pair reverse-phase high performance liquid chromatography method for determination of Huperzine-A in beagle dog serum

Ye, J., Zeng, S., Zhang, W., et al. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.12.002 · Cited by 15 · see citing works

Facilitation and inhibition of nicotinic transmission by eserine in the sympathetic ganglia of the rabbit

Mo, N. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90197-2 · Cited by 13 · see citing works

Effects of huperzine A on liver cytochrome P-450 in rats.

Ma, X., Wang, H.-X., Xin, J., Zhang, T., & Tu, Z.-H. (2003) · PubMed · Cited by 12 · see citing works

Comparison between huperzine A, tacrine, and E2020 on cholinergic transmission at mouse neuromuscular junction in vitro.

Lin, J., Hu, G., & Tang, X.-C. (1997) · PubMed · Cited by 11 · see citing works

[Facilitatory effects of huperzine A and B on learning amd memory of spatial discrimination in mice].

Zhu, X.-D., & Xc, T. (1987) · PubMed · Cited by 10 · see citing works

Cognition Improvement by Oral Huperzine A: A Novel Acetylcholinesterase Inhibitor

Tang, X., Xiong, Z. Q., Qian, B. C., et al. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_20 · Cited by 9 · see citing works

Introduction to Cholinesterase Inhibitors Used in Alzheimer’s Disease Therapy

Kumar, V. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_17 · Cited by 8 · see citing works

Facilitatory effect of huperzine-A on mouse neuromuscular transmission in vitro.

Lin, J., Hu, G., & Tang, X.-C. (1996) · PubMed · Cited by 6 · see citing works

Clinical Pharmacokinetics of Centrally Acting Cholinesterase Inhibitors

Hartvig, P., Wiklund, L., Aquilonius, S. M., et al. (1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6738-1_8 · Cited by 4 · see citing works

Potentiation of Acetylcholine Action by Huperzine-A and Physostigmine on Some Vertebrate Effectors, Including Human Iris Sphincter Muscle

Patil, K. D., Buerki, R. A., & Patil, P. N. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803321637663 · Cited by 4 · see citing works

Pilot trial of huperzine A to treat child language delay

Li, B. (2002) · Journal of Pediatric Pharmacy · Cited by 4 · see citing works

Huperzine A vs pyritinol in treating dementia from multiple infarctions

Jian, C. (1997) · Cited by 3 · see citing works

[Effects of huperzine A on cholinesterase isoenzymes in plasma of mice and dogs].

Hao, X.-Y., Gong, Z., & Qin, B.-Y. (1988) · PubMed · Cited by 3 · see citing works

A Clinical Study of the Effect of Huperzine A to Improve the Ability of Verbal Recall, Retention and Repetition in Middle-aged and Elderly Patients with Dysmnesia

Shu, C. (2002) · Yiyao daobao · Cited by 2 · see citing works

Huperzine A capsules vs tablets in treating senile amnesia: a double-blind study

Li, S., & Si, X. (2000) · Chinese Journal of New Drugs and Clinical Remedies · Cited by 2 · see citing works

Enhancement and depression of cholinergic transmission by 9-amino-1,2,3,4-tetrahydroacridine in rat superior cervical ganglia

Meng, W. (1993) · Zhongguo yaolixue tongbao · Cited by 2 · see citing works

[Facilitation of cholinergic transmission by huperzine A in toad paravertebral ganglia in vitro].

Zhang, G. B., Wang, M., Zheng, J., et al. (1994) · PubMed · Cited by 2 · see citing works

Huperzine A attenuates amyloid β-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation

Xiao, X. Q., Zhang, H., & Tang, X. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10075.abs · Cited by 2 · see citing works

Huperzine-A capsule in treatment of age-associated memory impairment with a double-blind study

Zhixu, G. (2003) · Sichuan Mental Health · Cited by 1 · see citing works

Impairment of hippocampal long-term potentiation by Alzheimer amyloid ?-peptides

Chen, Q.-S., Kagan, B. L., Hirakura, Y., & Xie, C.-W. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000401)60:1

The immune system’s role in sepsis progression, resolution, and long-term outcome

Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880 · see citing works

Natural products as a source of Alzheimer's drug leads

Williams, P., Sorribas, A., & Howes, M.-J. R. (2011) · Nat. Prod. Rep. · doi:10.1039/c0np00027b · Cited by 404 · see citing works

Autonomic neural regulation of immunity

CZURA, C. J., & TRACEY, K. J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01442.x · Cited by 255 · see citing works

Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease

Zhang, H. Y., & Tang, X. C. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.004 · Cited by 174 · see citing works

The intestinal cholinergic anti-inflammatory pathway

Goverse, G., Stakenborg, M., & Matteoli, G. (2016) · The Journal of Physiology · doi:10.1113/jp271537 · Cited by 109 · see citing works

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy

Arya, A., Chahal, R., Rao, R., Rahman, M. H., Kaushik, D., Akhtar, M. F., Saleem, A., Khalifa, S. M. A., El-Seedi, H. R., Kamel, M., et al. (2021) · Biomolecules · doi:10.3390/biom11030350 · Cited by 111 · see citing works

Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107 · see citing works

Whole blood cytokine attenuation by cholinergic agonists <i>ex vivo</i> and relationship to vagus nerve activity in rheumatoid arthritis

Bruchfeld, A., Goldstein, R. S., Chavan, S., Patel, N. B., Rosas‐Ballina, M., Kohn, N., Qureshi, A. R., & Tracey, K. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02226.x · Cited by 99 · see citing works

Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological disorders

Kamal, Z., Ullah, F., Ayaz, M., Sadiq, A., Ahmad, S., Zeb, A., Hussain, A., & Imran, M. (2015) · Biological Research · doi:10.1186/s40659-015-0011-1 · Cited by 86 · see citing works

Huperzine: A response to cognitive impairment and task switching deficits in patients with Alzheimer’s disease

Gul, A., Bakht, J., & Mehmood, F. (2019) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.07.004 · Cited by 52 · see citing works

Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice

Chen, H., Xiang, S., Huang, L., Lin, J., Hu, S., Mak, S., Wang, C., Wang, Q., Cui, W., & Han, Y. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0221-7 · Cited by 13 · see citing works

Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats

Ogura, H., Kosasa, T., Kuriya, Y., & Yamanishi, Y. (2000) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2000.22.2.796070 · Cited by 81 · see citing works

Huperzine A, a novel promising acetylcholinesterase inhibitor

Cheng, D. H., Ren, H., & Tang, X. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00020 · Cited by 130 · see citing works

Donepezil in Treatment of AD

Hsiung, G. R., & Feldman, H. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-661-4_20

Synthesis and evaluation of tacrine–Huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of alzheimer’s disease

Badı́a, A., Baños, J.-E., Camps, P., Contreras, J., GOERBIG, D. M., Muñoz‐Torrero, D., Simón, M., & Vivas, N. M. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00015-7 · Cited by 80 · see citing works